Part of Taylor & Francis, features the latest news, opinions, insight and more on #regenerativemedicine, #cellandgenetherapy in partnership with @Regen_Med
Joined February 2015
- Tweets 10,375
- Following 1,343
- Followers 4,513
- Likes 1,737
2,448 Photos and videos
Jun 10
Could gene therapy transform treatment for muscle spasticity after spinal cord injury?
Researchers have developed an AAV-based gene therapy that targets GABA signaling to dampen overactive nerve circuits that drive muscle spasticity >>> hubs.ly/Q04kLx3n0
55
Jun 9
How do MSC-derived exosomes deliver stem cell benefits without the cells themselves? This curated review of recent research highlights their emergence as transformative next-generation therapeutics >>> hubs.ly/Q04kGhS30
38
Jun 5
According to new research, stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment >>> hubs.ly/Q04kd_H30)
1
142
Jun 4
For cell therapy developers, automation delivers the consistency, efficiency and scalability essential for advancing programs through increasingly complex regulatory requirements. Read this case study detailing 80%-time savings at the bench from @ThermoFisher >>> hubs.ly/Q04gcNST0
33
Jun 4
Catch up on the latest news in cell and gene therapy >>> hubs.ly/Q04k4xjb0
This week:
👉 The FDA issued a draft guidance aiming to accelerate cell and gene therapies
👉 UK-based biotech company Laverock Therapeutics was awarded US$2.8 million in grants to support the development of its gene-control platform
👉 Legend Biotech presented clinical data on two of its CAR-T therapies at the #ASCO2026
47
Jun 4
We want to learn more about industry opinions on raw materials for cell and gene therapy manufacturing! Share your insights about the key factors influencing material selection, supply chain management and the transition to clinical manufacturing in this survey >>> hubs.ly/Q049SzdL0
35
Jun 1
As part of our In Focus on stem cells, we put Hagen Wieland, Team leader of Research and Development at PromoCell, in the hot seat to find out his expert tips on tackling variability, scaling processes, and leveraging cryopreservation for robust regenerative therapies >>> hubs.ly/Q04fXpnX0
1
1
54
May 29
⌛Three stories in three minutes >>> hubs.ly/Q04jlShR0
Catch up on top cell and gene therapy news on RegMedNet, including:
1️⃣Positive Phase I results for a single-dose base editing therapy for hypercholesterolemia
2️⃣The opening of 14,000-square-foot FDA-compliant manufacturing facility
3️⃣A $50 million investment to establish an advanced biomanufacturing and R&D center in Chicago
43
May 28
Are you interested in exploring key stages of stem cell therapy development and the critical steps needed to ensure consistency, scalability and functionality throughout the workflow?
Learn more in this infographic, ‘Stem cell therapy: Building reproducible and scalable workflows’! Download now! >>> hubs.ly/Q04fXyBS0
1
35
May 28
Researchers at the University of California San Diego School of Medicine have developed an experimental gene therapy that may help protect the brain from TDP-43-related proteinopathy – a type of neurodegeneration commonly seen in frontotemporal dementia, Alzheimer's disease and ALS. Read here: hubs.ly/Q04jb_2-0
1
1
150
May 28
What recent advances have been made in the development of xeno‑free and animal component‑free cell culture media? What are the broader industry trends that are shaping their development? Uncover insights from GMP and compliance experts at PromoCell >>> hubs.ly/Q04gcLgw0
41
May 26
This Saturday is World MS Day 🌍
To mark the day, we reviewed some recent advancements in MS research and examined current and emerging regenerative approaches that hold promise for enhancing treatment options: hubs.ly/Q04f5ryq0
22
May 26
Accurate cytokine profiling is essential for evaluating CAR T-cell efficacy and safety, especially for predicting cytokine release syndrome risk. This Application Note from @ThermoFisher shows automated workflows reducing hands-on time from 5 hours to just 45 minutes. Learn more about automated workflows >>> hubs.ly/Q04ghJhX0
46
May 25
Discover how xeno-free and animal component-free media reduce variability and contamination risks in cell-based therapies. Our Spotlight feature highlights the role of raw materials and supply chain resilience in enabling reproducible, patient-ready therapies >>> hubs.ly/Q049Sl0_0
1
61
May 25
A new 3D-printed scaffold tray developed by Cincinnati Children’s could help accelerate the production of gut organoids, offering solutions for scalable tissue repair >>> hubs.ly/Q04hGcQ10
63
May 22
A novel cytokine-armored CAR-T cell therapy has been developed by scientists at the UCLA Health Jonsson Comprehensive Cancer Center, aiming to tackle aggressive brain tumors >>> hubs.ly/Q04hGCXg0
1
64
May 21
Catch up on the latest news in cell and gene therapy >>> hubs.ly/Q04hx2J90
This week:
👉 HaemaLogiX announced the opening of its KOALA Phase I trial that will assess its KMCAR™ T-cell therapy
👉 Elpida Therapeutics and Catalent have announced a strategic partnership to support late-phase manufacturing of Elpida’s lead gene therapy program
👉 Protara Therapeutics has announced positive updated 12-month data from Cohort A of its ongoing Phase II ADVANCED trial evaluating its TARA-002 cell therapy
1
84
May 21
🧪 Simplify your reagent selection process! Explore PromoCell’s detailed specifications for human, animal and non-animal-derived components in this guide >>> hubs.ly/Q049SsHp0
37
May 19
Check out our roundup of recent advancements in CAR-T therapy >>> hubs.ly/Q04f6Q8s0
Explore the application of CAR-T therapy in hematological cancers, autoimmune diseases, solid tumors and tissue regeneration!
37
May 19
Survey: share your insights on raw materials and supply chain management for a chance to win a $50 voucher! RegMedNet wants to hear your thoughts on scaling cell therapies >>> hubs.ly/Q049SqvG0
81